IT:ICCM IceCure Medical Ltd.

IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.

398.80 ILS
As of 03/22/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/09/2011
Stock exchange:    Tel Aviv Stock Exchange
Exchange country:   Israel
Market cap:   230,067,328 ILS
Current dividend yield:   0.00%
Sedol:      B67PC92

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy